A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality Age range
18 Years – 75 Years
Last updated September 2025